Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03820141
Title Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer (DTP)
Acronym DTP
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jenny C. Chang, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field